• Viewpoint
    May 13, 2026

    Private markets are under pressure to move faster and show stronger evidence of performance and control. Deal sourcing and screening now span thousands of fragmented sources. Limited Partners (LPs) want continuous, verifiable visibility into fund and…
  • Tech Provider Spotlight
    Oct. 14, 2025

    Clinical trial complexity continues to increase with hybrid study models, diverse data sources, and growing regulatory expectations, making traditional oversight models inadequate. Conventional monitoring approaches reliant on 100% source data verification and frequent on-site visits are…